APLN and diabetes mellitus: Apelin can maintain β-cell identity in mice in the HFD and STZ models of diabetes, ensuring maintenance of β-cell mass, and also contributes to a decrease in apoptosis and to increased β-cell proliferation (Gao et al., 2018; Tanday et al., 2020).